170 related articles for article (PubMed ID: 2385012)
1. Effects of KB-5492, 1-(3,4,5-trimethoxybenzyl)-4-((4-methoxyphenyl)oxycarbonylmethyl) p iperazine monofumarate monohydrate, on gastric lesions and gastric secretion in rats.
Shimohara K; Niida H; Okabe S
Jpn J Pharmacol; 1990 Jun; 53(2):275-9. PubMed ID: 2385012
[TBL] [Abstract][Full Text] [Related]
2. Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats.
Hara H; Tanaka K; Harada Y; Sukamoto T
J Pharmacol Exp Ther; 1994 May; 269(2):799-805. PubMed ID: 8182548
[TBL] [Abstract][Full Text] [Related]
3. Effects of sofalcone on necrotizing agents-induced gastric lesions and on endogenous prostaglandins in rats stomachs.
Saziki R; Arai I; Isobe Y; Hirose H; Aihara H
J Pharmacobiodyn; 1984 Nov; 7(11):791-7. PubMed ID: 6597872
[TBL] [Abstract][Full Text] [Related]
4. Cytoprotective effect of sofalcone in the rat gastric mucosa.
Isobe Y; Hirose H; Muramatsu M; Aihara H
Arzneimittelforschung; 1985; 35(1):138-41. PubMed ID: 3857044
[TBL] [Abstract][Full Text] [Related]
5. Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine.
Morimoto Y; Shimohara K; Oshima S; Sukamoto T
Jpn J Pharmacol; 1991 Dec; 57(4):495-505. PubMed ID: 1803065
[TBL] [Abstract][Full Text] [Related]
6. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
7. Effect of 10% ethanol and sofalcone on prostaglandin E2 content, mucus gel thickness, and experimental ulcers in the stomach of developing rats.
Tabata M; Tomomasa T; Itoh K; Morikawa A
Digestion; 1996; 57(1):47-53. PubMed ID: 8626048
[TBL] [Abstract][Full Text] [Related]
8. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
[TBL] [Abstract][Full Text] [Related]
10. Effect of an anti-ulcer agent, 2'-carboxymethoxy-4, 4'-bis (3-methyl-2-butenyloxy) chalcone (SU-88), on the biosynthesis of gastric sulfated mucosubstances in restrained and water-immersed rats.
Suwa T; Fukushima K; Kyogoku K; Edo H; Mori Y
Jpn J Pharmacol; 1984 Jan; 34(1):89-94. PubMed ID: 6716720
[TBL] [Abstract][Full Text] [Related]
11. Effects of a crude extract of a marine dinoflagellate, containing dimethyl-beta-propiothetin, on HCl.ethanol-induced gastric lesions and gastric secretion in rats.
Ishida Y; Ogihara Y; Okabe S
Jpn J Pharmacol; 1990 Nov; 54(3):333-8. PubMed ID: 2090842
[TBL] [Abstract][Full Text] [Related]
12. Alteration of basic fibroblast growth factor concentration and immunoreactivity in healing of ethanol-induced gastric mucosal damage: effect of sofalcone.
Nakamura M; Akiba Y; Oda M; Ishii H
J Clin Gastroenterol; 1997; 25 Suppl 1():S13-20. PubMed ID: 9479622
[TBL] [Abstract][Full Text] [Related]
13. Effects of a new benzimidazole derivative, NC-1300-O-3, on gastric secretion and gastroduodenal lesions in rats.
Okabe S; Akimoto Y; Yamasaki S; Kuwahara K
Jpn J Pharmacol; 1991 Apr; 55(4):477-91. PubMed ID: 1832198
[TBL] [Abstract][Full Text] [Related]
14. Effects of N-acetyl-L-carnosine aluminum (CL-1700) on various acute gastric lesions and gastric secretion in rats.
Okabe S; Kunimi H
Jpn J Pharmacol; 1981 Dec; 31(6):941-50. PubMed ID: 7334737
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 15-hydroxy prostaglandin dehydrogenase and increase of prostaglandin E2: effect of sofalcone on rat gastric mucosa.
Muramatsu M; Tanaka M; Murakami S; Aihara H
Life Sci; 1987 Jul; 41(3):315-22. PubMed ID: 3474485
[TBL] [Abstract][Full Text] [Related]
16. Effects of MCI-727, a new antiulcer agent, on various gastric and duodenal lesions in experimental animals.
Yamazaki S; Kawamura M; Kitsukawa M; Ando K; Nitta I; Tobe A; Okabe S
Jpn J Pharmacol; 1991 Apr; 55(4):415-24. PubMed ID: 1886287
[TBL] [Abstract][Full Text] [Related]
17. [Effects of the anti-ulcer agents on the amine contents and regulating enzyme activity of gastric mucosa during the healing process of acetic acid induced gastric ulcer in rats].
Omata T; Inoue H; Seyama Y; Yamashita S
Nihon Yakurigaku Zasshi; 1990 Jan; 95(1):15-20. PubMed ID: 1968027
[TBL] [Abstract][Full Text] [Related]
18. Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats.
Tanaka J; Iida H; Abe M; Yuda Y; Inoue S; Okabe S
Arzneimittelforschung; 2004; 54(4):221-9. PubMed ID: 15146935
[TBL] [Abstract][Full Text] [Related]
19. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
Okabe S; Narita M; Nakaji S; Takinami Y; Kawano O; Misaki N
Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631
[TBL] [Abstract][Full Text] [Related]
20. [Effects of 2-benzyloxycarbonylphenyl trans-4-guanidinomethylcyclohexanecarboxylate hydrochloride monohydrate (TKG01) and its clathrate compound with beta-cyclodextrin (TA903) on experimental gastric ulcers and gastric secretion in rats].
Tanaka I; Tagami H
Nihon Yakurigaku Zasshi; 1985 Mar; 85(3):167-71. PubMed ID: 3924794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
